Method and system for characterization and mapping of tissue lesions
AssigneeForth Photonics Ltd.
InventorsKonstantinos Balas, Demetrios Pelecoudas
Life of this patent
Estimating the term…
Loading patent…
AssigneeForth Photonics Ltd.
InventorsKonstantinos Balas, Demetrios Pelecoudas
Estimating the term…
The present invention provides a method and an apparatus for the in vivo, non-invasive, early detection of alterations and mapping of the grade of these alterations, caused in the biochemical and/or in the functional characteristics of epithelial tissues during the development of tissue atypias, dysplasias, neoplasias and cancers. The method is based, at least in part, on the simultaneous measurement of the spatial, temporal and spectral alterations in the characteristics of the light that is re-emitted from the tissue under examination, as a result of a combined tissue excitation with light and special chemical agents. The topical or systematic administration of these agents result in an evanescent contrast enhancement between normal and abnormal areas of tissue. The apparatus enables the capturing of temporally successive imaging in one or more spectral bands simultaneously. Based on the measured data, the characteristic curves that express the agent-tissue interaction kinetics, as well as numerical parameters derived from these data, are determined in any spatial point of the examined area. Mapping and characterization of the lesion, are based on these parameters.
Use of a differentiating agent in a method for monitoring the effects of said pathology differentiating agent on a tissue, comprising:
Use of a differentiating agent in a method for monitoring the effects of said pathology differentiating agent on a tissue, comprising:
Use of a differentiating agent in a method for monitoring the effects of said pathology differentiating agent on a tissue, the method comprising:
Use of a differentiating agent in a method for monitoring and mapping the effects of said pathology differentiating agent on a tissue, comprising:
The use of a differentiating agent in a method for the in vivo diagnosis and mapping of a tissue abnormality in a subject, comprising
A system for diagnosing and mapping a tissue abnormality, the system comprising a detector for measuring a difference in a dynamic optical property between a normal tissue and an abnormal tissue, said difference being caused by applying a pathology differentiating agent to the tissue.
An apparatus for the in vivo diagnosis and mapping of a tissue abnormality comprising
A system for diagnosing and mapping a tissue abnormality, the system comprising:
Dependencies are inferred from the claim text.